Compare NWL & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWL | BHC |
|---|---|---|
| Founded | 1903 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.1B |
| IPO Year | 1995 | 1996 |
| Metric | NWL | BHC |
|---|---|---|
| Price | $5.62 | $5.98 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 7 |
| Target Price | $6.66 | ★ $7.50 |
| AVG Volume (30 Days) | ★ 5.1M | 1.7M |
| Earning Date | 10-30-2026 | 10-28-2026 |
| Dividend Yield | ★ 4.96% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $14,742,200,000.00 | $8,724,000,000.00 |
| Revenue This Year | $1.75 | $6.05 |
| Revenue Next Year | $1.48 | N/A |
| P/E Ratio | $33.20 | ★ N/A |
| Revenue Growth | ★ 11.14 | N/A |
| 52 Week Low | $3.07 | $4.33 |
| 52 Week High | $7.13 | $8.00 |
| Indicator | NWL | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 50.50 |
| Support Level | $4.95 | $5.44 |
| Resistance Level | $6.28 | $6.31 |
| Average True Range (ATR) | 0.19 | 0.24 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 66.90 | 52.80 |
Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.